BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15101847)

  • 1. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain.
    Rømsing J; Møiniche S
    Acta Anaesthesiol Scand; 2004 May; 48(5):525-46. PubMed ID: 15101847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacology of the selective COX-2 inhibitors].
    Burian M; Geisslinger G
    Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
    Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
    Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.
    Reuben SS; Connelly NR
    Anesth Analg; 2000 Nov; 91(5):1221-5. PubMed ID: 11049912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control.
    Chen LC; Elliott RA; Ashcroft DM
    J Clin Pharm Ther; 2004 Jun; 29(3):215-29. PubMed ID: 15153083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.
    Malmstrom K; Fricke JR; Kotey P; Kress B; Morrison B
    Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain.
    Kellstein D; Ott D; Jayawardene S; Fricke J
    Int J Clin Pract; 2004 Mar; 58(3):244-50. PubMed ID: 15117090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
    JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclooxygenase-2 inhibitors in postoperative pain management].
    Güneş Y; Işik G
    Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ; Figgitt DP
    Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery.
    Watcha MF; Issioui T; Klein KW; White PF
    Anesth Analg; 2003 Apr; 96(4):987-994. PubMed ID: 12651647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC
    Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.
    Moore PA; Hersh EV
    J Am Dent Assoc; 2001 Apr; 132(4):451-6. PubMed ID: 11315375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery.
    Fricke J; Varkalis J; Zwillich S; Adler R; Forester E; Recker DP; Verburg KM
    Am J Ther; 2002; 9(2):89-97. PubMed ID: 11897923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative oral celecoxib versus preoperative oral rofecoxib for pain relief after thyroid surgery.
    Karamanlioğlu B; Arar C; Alagöl A; Colak A; Gemlik I; Süt N
    Eur J Anaesthesiol; 2003 Jun; 20(6):490-5. PubMed ID: 12803270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cox-2 inhibitors: today and tomorrow.
    McMurray RW; Hardy KJ
    Am J Med Sci; 2002 Apr; 323(4):181-9. PubMed ID: 12003372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.